ArticleScientific reports2025
Burden of subarachnoid hemorrhage in Asia and ARIMA model prediction trends from 1990 to 2021.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating expert decision-pattern alignment in endovascular planning for intracranial aneurysms using a multimodal large language model.Neuroradiology · 2026Article
- Trends in mortality and disability-adjusted life years (DALYs) attributable to subarachnoid hemorrhage in South Asia (2000-2023).Neurosurgical review · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Subarachnoid hemorrhage (SAH) is a rare but serious stroke subtype that accounts for approximately 5% of all strokes. This study analyzed SAH epidemiology in Asia from 1990 to 2021 using the Global Burden of Disease (GBD) 2021 data. This study assessed the burden of SAH in Asia using four indicators: incidence, prevalence, mortality, and disability-adjusted life years (DALYs). An autoregressive integrated moving average (ARIMA) model was used to conduct a long-term trend analysis and forecast the changing trends of various indicators from 2022 to 2041. Between 1990 and 2021, the age-standardized incidence rates (ASIR) of SAH in Asia increased and then decreased, while the age-standardized prevalence rates (ASPR), age-standardized mortality rates (ASMR), and age-standardized disability-adjusted life years rates (ASDR) of SAH continued to decline. The Arima model predictions suggest that Asian age-standardized rates will typically show a decreasing trend over the next 20 years, except for the ASIR, which shows an increasing trend. Over the next 20 years, the ASIR of SAH in Asia is expected to increase. The ASPR, ASMR, and ASDR were expected to show decreasing trends. The burden of SAH in older patients remains high, highlighting the need to strengthen the health management of the older population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.